Showing results (131-140 of 143) with videos related to
Sort By:
Pageof 15
Scientific Reports|November 29, 2023
1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitorsMaurício T Tavares, Arne Krüger, Sun L Rei Yan, et al.Cancer Research|November 29, 2013
Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesisJoanne R Doherty, Chunying Yang, Kristen E N Scott, et al.European Journal of Medicinal Chemistry|November 21, 2023
HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agentsKaroline B Waitman, Larissa C de Almeida, Marina C Primi, et al.Journal of Medicinal Chemistry|November 16, 2021
Oxidative Metabolism as a Modulator of Kratom's Biological ActionsSoumen Chakraborty, Rajendra Uprety, Samuel T Slocum, et al.Nature|November 30, 2022
Structure-based design of bitopic ligands for the µ-opioid receptorAbdelfattah Faouzi, Haoqing Wang, Saheem A Zaidi, et al.Journal of Medicinal Chemistry|November 21, 2022
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for GlioblastomaLakshmi R Bollu, Prashant V Bommi, Paige J Monsen, et al.Nature Cancer|April 15, 2022
An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancerCiric To, Tyler S Beyett, Jaebong Jang, et al.Biorxiv : the Preprint Server for Biology|October 17, 2024
Development of Clinically Viable Non-Muscle Myosin II Small Molecule Inhibitors with Broad Therapeutic PotentialLaszlo Radnai, Erica J Young, Carlos Kikuti, et al.Biorxiv : the Preprint Server for Biology|April 15, 2026
A SARS-CoV-2 entry inhibitor trimerizes to lock the spike protein in a closed conformationHuihui Mou, Bo Gao, Gang Ye, et al.Cell|July 2, 2025
Development of clinically viable non-muscle myosin II small molecule inhibitorsLaszlo Radnai, Erica J Young, Carlos Kikuti, et al.Pageof 15